Kazmira and Companion Sciences Announce Strategic Partnership to Commercialize Revolutionary New CBD Joint Mobility Product
Kazmira entered into a strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and commercialize its joint mobility supplement in the US.
The partnership provides Kazmira with exclusive rights to manufacture and distribute a line of consumer products utilizing Companion Sciences’ IP.
(Watkins, CO – February 21, 2022) – Kazmira, a vertically integrated cannabinoid manufacturer with patent protected purification technology – who received a $50M minority investment from Perrigo, (NYSE: PRGO) in June of 2020 – today announced a significant strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and commercialize its joint mobility supplement in the US.
The partnership provides Kazmira with exclusive rights to manufacture and distribute a line of consumer products – through all channels – based on Companion Sciences’ IP and know-how. The products will address pain and inflammation symptoms related to a variety of joint conditions.
“We look forward to continuing our development and commercialization journey with Companion Sciences,” commented Co-CEO Pulak Sharma of Kazmira. “They are precisely the kind of science-based, research-led start-up that can leverage our innovative and trusted THC-free CBD products.”
“We are very excited about this partnership” said Golan Vaknin, CEO of Companion Sciences. “Partnering with Kazmira, who is so well-respected for their relentless pursuit of offering safer, higher-performing, innovative Cannabinoid product solutions, is an enormous validation of our underlying science. We look forward to working collaboratively to advance and commercialize this breakthrough product, which has the ability to materially improve the quality of life for millions.”
Kazmira’s mission is to use a science-based approach to improve life through self-care, cannabinoid-based, dietary supplement products. As an industry leading manufacturer of premium hemp derived cannabinoid ingredients, we enable brands to offer safer, higher performing, and innovative products. Kazmira is invested in the future of the cannabinoid industry with a passion for partnerships, R&D and cannabinoid policy. In addition to our wholesale, THC-free cannabinoid extracts, we offer a range of finished & custom end products. From the farm to the finished product, our oversight and quality assessment ensures the finest quality cannabinoid extracts on the market
About COMPANION SCIENCES:
Companion Sciences is a life-sciences company with a research focus on novel formulations of CBD that potentiate the bio-absorption of a range of nutraceuticals and food supplements, while simultaneously enhancing the availability of CBD itself. We are pursuing patent-protected formulations that address a range of needs, among people and pets, related to physical and emotional well-being.